Credit: Hofseth BioCare |
Hofseth BioCare (HBC), a Norwegian consumer and pet health ingredient supplier that utilizes Atlantic salmon, is building a second hydrolysis plant to triple its production capacity.
The company said the new facility will be located in Berkåk, Norway, and will be built through a wholly owned subsidiary of HBC dubbed Hofseth Berkåk. The new facility will manufacture, market, and sell human-grade marine proteins, collagens, and oils that use Atlantic salmon raised in Norway as an ingredient. |
|
|